Literature DB >> 16490137

A community outbreak of tuberculosis in Southern Austria: lessons learned for a targeted use of molecular epidemiological methods and tuberculin skin testing.

D Schmid1, A Indra, G Höger, P Hasenberger, B Robl, M Schöffmann, B Maieron, G Olexsinski, B Stonitsch, W M Prodinger, F Allerberger.   

Abstract

A cluster of 10 cases of tuberculosis disease (one of them extrapulmonary) occurred from July 2001 until November 2003 in a health district in Southern Austria. Eight patients were culture confirmed and shared an identical strain. One of these eight cases was identified as outbreak-related by molecular strain typing only. Due to public pressure, a further 600 persons received chest X-ray and clinical examinations. Apart from one case which could be excluded from the outbreak because of a different strain pattern, no outbreak-related case of active tuberculosis was detected by this non-targeted procedure. Tuberculin skin testing, not part of the Austrian routine protocol of contact investigation in adults, was initiated after diagnosis of case 8. Forty-nine latently infected contacts were detected. Population-based genotyping of all isolates, prioritization of contact investigations and early use of targeted tuberculin skin testing are critical for effective tuberculosis control in low-incidence countries.

Entities:  

Mesh:

Year:  2006        PMID: 16490137      PMCID: PMC2870399          DOI: 10.1017/S0950268805005078

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  9 in total

Review 1.  Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

2.  An outbreak of suppurative lymphadenitis connected with BCG vaccination in Austria, 1990/1991.

Authors:  F Allerberger
Journal:  Am Rev Respir Dis       Date:  1991-08

3.  Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology.

Authors:  J D van Embden; M D Cave; J T Crawford; J W Dale; K D Eisenach; B Gicquel; P Hermans; C Martin; R McAdam; T M Shinnick
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

Review 4.  Control and prevention of tuberculosis in the United Kingdom: code of practice 2000. Joint Tuberculosis Committee of the British Thoracic Society.

Authors: 
Journal:  Thorax       Date:  2000-11       Impact factor: 9.139

Review 5.  European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis Association (KNCV) Working Group.

Authors:  J F Broekmans; G B Migliori; H L Rieder; J Lees; P Ruutu; R Loddenkemper; M C Raviglione
Journal:  Eur Respir J       Date:  2002-04       Impact factor: 16.671

6.  Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units.

Authors:  P Supply; S Lesjean; E Savine; K Kremer; D van Soolingen; C Locht
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

7.  Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology.

Authors:  J Kamerbeek; L Schouls; A Kolk; M van Agterveld; D van Soolingen; S Kuijper; A Bunschoten; H Molhuizen; R Shaw; M Goyal; J van Embden
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

8.  Simultaneous infection with two drug-susceptible Mycobacterium tuberculosis strains in an immunocompetent host.

Authors:  M Pavlic; F Allerberger; M P Dierich; W M Prodinger
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

9.  A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements.

Authors:  L Wang; M O Turner; R K Elwood; M Schulzer; J M FitzGerald
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

  9 in total
  2 in total

1.  Use of PCR-based Mycobacterium tuberculosis genotyping to prioritize tuberculosis outbreak control activities.

Authors:  Maegan Ashworth; Kathleen L Horan; Robert Freeman; Eyal Oren; Masahiro Narita; Gerard A Cangelosi
Journal:  J Clin Microbiol       Date:  2008-01-03       Impact factor: 5.948

Review 2.  Molecular epidemiology of tuberculosis: toy or tool? A review of the literature and examples from Central Europe.

Authors:  Wolfgang M Prodinger
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.